+ Translate

The primary structure of human urogastrone

, : The primary structure of human urogastrone. International Journal of Peptide and Protein Research 9(2): 107-118

Urogastrone is a potent inhibitor of gastric acid secretion which is present in human urine. Its existence has been known for over 30 years but it has only recently been isolated in a sufficiently pure form for detailed structural studies to be undertaken. Two separate polypeptides beta- and gamma-urogastrone were isolated. The structures were established by carrying out enzymic degradations of S-carboxymethyl and S-carboxamidomethyl derivatives with trypsin, chymotrypsin, thermolysin and a protease derived from the fungus Armillaria mellea. Sequences of the smaller peptides thus obtained were determined by the dansyl Edman method. Partial acid hydrolysis of urogastrone itself gave fragments containing single intact disulphide bonds, and oxidation then allowed the direction of individual bonds to be established. Beta-Urogastrone was shown to be a 53-amino acid residue polypeptide containing three disulphide bonds, and gamma-urogastrone had an identical sequence but lacked the C-terminal arginine residue. Urogastrone was subsequently found to be structurally related to mouse epidermal growth factor in that 37 of the 53 residues were commonly located in each polypeptide. Furthermore, as both peptides has similar effects upon gastric acid secretion and upon epidermal growth, urogastrone was also a human epidermal growth factor. The 16 variable residues were spread across the molecule, all apart from two were compatible with single base changes in the triplet condons, and the overall effect was to make uorgastrone more acidic than EGF. The smallest biologically active unit has not been defined but at least six residues can be removed from the C-terminus without causing a reduction in potency.

(PDF 0-2 workdays service)

Accession: 041721915

PMID: 300079

Submit PDF Full Text: Here

Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:

Related references

Neya, M.; Hagiwara, D.; Hemmi, K.; Hashimoto, M., 1989: Total synthesis of urogastrone human epidermal growth factor h egf part 2. synthesis of urogastrone having the structure proposed for the natural compound. Deprotection of the fully protected urogastrone was carried out by a two-step deprotection strategy. In the first step the protecting groups of all side-chain functional groups except for the cysteine thiol were removed by treatment with HF and th...

Neya, M.; Hagiwara, D.; Miyazaki, Y.; Nakamura, T.; Hemmi, K.; Hashimoto, M., 1989: Total synthesis of urogastrone human epidermal growth factor h egf part 1. synthesis of the fully protected urogastrone. The first total synthesis of urogastrone (h-EGF) has been achieved by the segment condensation method in solution applying the maximum protection strategy with a two-step deprotection procedure. The polypeptide chain was constructed from 10 small...

Costrini, N.V.; Beck, R., 1983: Epidermal growth factor-urogastrone receptors in normal human liver and primary hepatoma. Epidermal growth factor-urogastrone (EGF-URO) receptors have been demonstrated in rodent liver and modulation of ligand binding during transformation has been shown in a variety of study systems. A patient presented with a resectable primary hepat...

Scheving, L.A., 1983: Primary amino acid sequence similarity between human epidermal growth factor-urogastrone, human pancreatic secretory trypsin inhibitor, and members of porcine secretin family. Sequence similarities are detected between human epidermal growth factor-urogastrone, human pancreatic secretory trypsin inhibitor, and members of the secretin family of gastrointestinal hormones, particularly gastric inhibitory peptide. These sim...

Morimoto, T.; Yamamoto, M., 1969: Studies of inhibitory substances of gastric secretion. I. Isolation of urogastrone from human primary pregnancy and non-pregnancy urine. Yakugaku Zasshi 89(2): 215-221

Anonymous, 1967: Studies on urogastrone VI Identification of an inactive fraction of crude urogastrone

Yamamoto M., 1969: Studies of inhibitory substances of gastric secretion part 1 isolation of urogastrone from human primary pregnancy and non pregnancy urine. Yakugaku Zasshi: 215-221

Saxena S.K.; Thompson J.S.; Joshi S.S.; Sharp J.G., 1992: Association of radiolabeled urogastrone binding with regenerating intestinal mucosa and epidermal growth factor urogastrone producing organs in rat. In the present study, we have tested the hypothesis that the regeneration of intestinal epithelium is regulated by changes in the uptake of radiolabeled recombinant human urogastrone (125I rhUG) in the regenerating mucosa and epidermal growth fact...

Anonymous, 1988: Synthetic urogastrone gene corresponding plasmid recombinants transformed cells production thereof and urogastrone expression us patent 4719180 january 12 1988

Kratzin, H.; Altevogt, P.; Kortt, A.; Ruban, E.; Hilschmann, N., 1978: Rule of antibody structure: the primary structure of a human monoclonal IgA1-immunoglobulin (myeloma protein Tro), V. The arrangement of the tryptic peptides and a discussion of the complete primary structure of the H-chain. This communication deals with the sequence work done with tryptic and chymotryptic peptides and some cyanogen bromide splitting products. With these peptides, and if necessary with their splitting peptides, the whole primary structure of the alpha...